Precision Medical Ventures announces the acquisition of Mindshare Medical to accelerate commercialization of RevealAI-Lung, a CADx software application with EU and Canadian regulatory approval.

Seattle, WA – March 23, 2021 – Precision Medical Ventures (PMV), an investment group led by Radiology and Health Care industry veterans, today announced the acquisition of substantially all of the assets of Mindshare Medical. PMV will do business under the Mindshare Medical name, which PMV acquired as part of the acquisition. Michael Calhoun will join PMV as Chief Executive Officer.

Michael Calhoun, CEO of Mindshare, said, “We’re excited to join forces with PMV. Their expertise in the industry will be incredibly valuable as we expand the reach of RevealAI. Our combined vision is to increase the clinical value of imaging, and their team has a deep understanding of how to deliver impactful products like RevealAI into clinical practice.”

Chris Wood, President of PMV, said, “We are thrilled to be working with Michael and continuing the Mindshare mission to extract subvisual data from radiographic imaging and leverage this data into clinically relevant insights. We see a future where diagnosis, prediction, prognosis and treatment response can all be improved using the techniques Mindshare developed. We are confident Mindshare will give providers the AI tools they have been desperately looking for.”

About Mindshare Medical
Mindshare Medical has developed RevealAI-Lung, the world’s first CADx software for the characterization of lung nodules to receive regulatory clearance. The RevealAI-Lung software has been validated with results that improve outcomes and save health systems significant cost in management of lung nodules, which are found on over a third of Chest CT scans and result in > $5B in unnecessary procedures each year in the US alone.

About Precision Medical Ventures
PMV is an investment group consisting of radiology and healthcare industry veterans, including executives and founders from PACS, Precision Medicine, CAD and MRI.